Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00640146 · ClinicalTrials.gov registry record · Phase 2
Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
NCT00640146 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 37 participants.
The verdict
NCT00640146, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the safety and activity of MNTX in relieving opioid-induced constipation following orthopedic procedures.
Interventions
- DRUG Placebo
- DRUG Methylnaltrexone bromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-10-19 |
| Est. Completion | 2009-01-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00640146
The ClinicalTrials.gov registry entry for NCT00640146 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00640146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00640146 about?
NCT00640146 is a clinical study titled "Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures". The purpose of this study is to examine the safety and activity of MNTX in relieving opioid-induced constipation following orthopedic procedures.
What is the current status of trial NCT00640146?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2007-10-19. Estimated completion is 2009-01-21.
What interventions are being tested in trial NCT00640146?
The interventions under investigation include: Placebo (DRUG), Methylnaltrexone bromide (DRUG).
Who is sponsoring clinical trial NCT00640146?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.